ArticleExploration of targeted anti-tumor therapy2025
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines.
Paweł Kochany et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.